Stock Market Moves On From SpaceX With Iran Deal, Fed in Focus

SpaceX completed the biggest-ever IPO, a transformative milestone that vaulted the company into the ranks of the largest public companies. The offering is described as history-making and puts founder Elon Musk on the verge of becoming the world’s first trillionaire. The event is highly positive for SpaceX and could have meaningful spillover effects for the IPO market and late-stage private tech valuations.

Analysis

This is less a single-stock event than a regime shift in private-capital liquidity. A marquee IPO of this scale typically re-prices the entire venture late-stage stack: secondary discounts should compress, crossover funds get a mark-to-market lift, and boards at the next wave of category leaders will push for listings sooner rather than later. The second-order effect is a bid for the enablers of capital formation — exchange infrastructure, listing advisors, market makers, and prime brokers — because deal flow and trading intensity usually rise together after a landmark offering.

For Morgan Stanley, the direct economics are not the headline; the durable benefit is franchise reinforcement. If this becomes a template deal, MS gains incremental share in ECM mandates, sponsor coverage, and post-IPO derivatives/financing business, with the real upside showing up over the next 2-6 quarters rather than immediately in this print. The more important question is whether the market is underestimating follow-on supply: large successful debuts often unlock a backlog of private assets that can pressure secondary pricing and absorb risk appetite away from other growth names.

The contrarian risk is that the first few days are the best of it. Mega-IPOs often attract momentum capital, but after the celebration, the stock can become a volatility source as insider lockup expectations, retail enthusiasm, and index inclusion mechanics fade into a slower fundamental ownership base. If the broader market turns risk-off, the most expensive private-market beneficiaries can underperform because they are financed by the same liquidity conditions that made the IPO possible.

Key Decisions for Investors

• Long MS vs. KRE or XLF basket for 1-3 months: own the firm with the clearest ECM/IPO franchise uplift while hedging broader financial beta; target modest upside with lower drawdown than a naked MS long.
• Buy MS call spreads 2-4 months out on any post-IPO consolidation day: structure for a rerating from franchise visibility rather than chasing an opening-day spike; risk/reward is better after volatility mean reverts.
• Short a basket of late-stage private-market proxies or recent high-multiple software names for 4-8 weeks: use the deal as a liquidity magnet thesis, expecting some rotation out of crowded growth exposure into fresh issuance.
• Watch secondary-market late-stage venture funds and feeder vehicles over the next 1-2 quarters; if pricing tightens, fade the move with puts or pair shorts because the follow-on supply pipeline can overwhelm demand.
• If MS fails to outperform financials within 2 weeks, take profits quickly: the market may already be pricing the franchise benefit, and the trade then becomes a crowded event-driven long with limited incremental upside.